Corcept Therapeutics Incorporated
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $31.1M | $51.5M | $40.4M | $24.2M | $54.9M | $93.0M | $39.6M | $24.6M |
| Accounts Receivable | $15.3M | $9.9M | $6.2M | $3.3M | $1.4M | $557.0K | — | — |
| Inventory | $4.6M | $2.3M | $1.7M | $1.2M | $1.1M | $853.0K | — | — |
| Total Current Assets | $124.2M | $65.7M | $49.0M | $30.2M | $58.3M | $95.1M | $39.8M | $25.0M |
| Property, Plant & Equipment | $518.0K | $205.0K | $98.0K | $236.0K | $203.0K | $150.0K | $26.0K | $4.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $220.5M | $68.8M | $51.9M | $34.6M | $63.1M | $99.2M | $39.8M | $25.1M |
| Liabilities | ||||||||
| Accounts Payable | $8.6M | $2.3M | $1.3M | $1.9M | $2.4M | $3.8M | $3.6M | $817.0K |
| Total Current Liabilities | $29.6M | $27.4M | $20.9M | $13.6M | $12.7M | $8.4M | $5.0M | $3.9M |
| Long-Term Debt | $0 | $0 | $12.5M | $24.5M | $29.3M | $29.0M | — | — |
| Total Liabilities | $29.6M | $27.4M | $33.4M | $38.0M | $42.1M | $37.4M | $5.0M | $3.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-193.1M | $-322.3M | $-330.4M | $-324.0M | $-292.6M | $-246.6M | $-208.6M | $-176.2M |
| Total Stockholders' Equity | $191.0M | $41.4M | $18.5M | $-3.4M | $21.0M | $61.8M | $34.8M | $21.2M |